Stuart A. Arbuckle

VERTEX PHARMACEUTICALS

EVP & Chief Commercial Officer

Overview

Stuart A. Arbuckle received an average compensation of $7,841,769 at VERTEX PHARMACEUTICALS from 2012 to 2016.

Annual data

2016

Non-Equity Incentive Plan$420,000
Option Awards$1,305,144
Salary$672,885
Stock Awards$3,150,148
Other$12,885
Total$5,561,062

In 2016, Stuart A. Arbuckle earned a total compensation of $5,561,062 as EVP & Chief Commercial Officer at VERTEX PHARMACEUTICALS INC.

Arbuckle received $3,150,148 in stock awards, which accounts for 56.65% of total compensation.

Arbuckle also received $420,000 in non-equity incentive plan, $1,305,144 in option awards, $672,885 in salary and $12,885 in other compensation.